Page 13 - ASME AM3D/IDETC/CIE 2015 Program
P. 13
WELCOME LETTERS IDETC/CIE
8th Frontiers in Biomedical Devices (BIOMED)
On behalf of the ASME Design Engineering Division, we are pleased to
welcome you to the 8th Frontiers in Medical Devices (BIOMED)
Conference. The BIOMED conference is intended to provide a cutting-
edge forum for design and manufacturing engineers to discuss new
medical device technologies and strategies for their development and
evaluation. In addition to discussing research and technology
development topics of interest to the bioengineering research
community, we also seek to address interests in clinical research and
regulatory issues in this exciting and rapidly evolving landscape.
We have an exciting program, with 20 technical presentations organized
into 5 sessions. We also look forward to an enlightening keynote talk
about Innovation in Medical Devices by Andrew J. Carter, Chief
Technology Officer at TheraCell, Inc.
We extend our thanks to all the authors, session chairs, and reviewers
who have contributed to the overall success of the conference. Special
thanks are due to the symposium chairs – Chad Smith, Linxia Gu, Jason
Moore, Loretta McHugh, and Xiaoli Zhang – whose strong support was a
great help in producing a quality conference program.
We hope that you enjoy the conference and look forward to continued
interactions in the future.
Carl Nelson
Conference Chair
University of Nebraska–Lincoln
Brian Jensen
Program Chair
Brigham Young University
13
8th Frontiers in Biomedical Devices (BIOMED)
On behalf of the ASME Design Engineering Division, we are pleased to
welcome you to the 8th Frontiers in Medical Devices (BIOMED)
Conference. The BIOMED conference is intended to provide a cutting-
edge forum for design and manufacturing engineers to discuss new
medical device technologies and strategies for their development and
evaluation. In addition to discussing research and technology
development topics of interest to the bioengineering research
community, we also seek to address interests in clinical research and
regulatory issues in this exciting and rapidly evolving landscape.
We have an exciting program, with 20 technical presentations organized
into 5 sessions. We also look forward to an enlightening keynote talk
about Innovation in Medical Devices by Andrew J. Carter, Chief
Technology Officer at TheraCell, Inc.
We extend our thanks to all the authors, session chairs, and reviewers
who have contributed to the overall success of the conference. Special
thanks are due to the symposium chairs – Chad Smith, Linxia Gu, Jason
Moore, Loretta McHugh, and Xiaoli Zhang – whose strong support was a
great help in producing a quality conference program.
We hope that you enjoy the conference and look forward to continued
interactions in the future.
Carl Nelson
Conference Chair
University of Nebraska–Lincoln
Brian Jensen
Program Chair
Brigham Young University
13
